The system can lock its payload in place and control how it is released
A new injectable material designed to deliver drug therapies and sensor technology to targeted areas within the human body is being developed by a Texas A&M University biomedical engineer who says the system can lock its payload in place and control how it is released.
The research, led by Michael McShane, professor in the Department of Biomedical Engineering who specializes in biomaterials, and graduate student Jason Roberts, appears in “Journal of Materials Chemistry B.” It details the development of a carrier system embedded with microscopic capsules that act as tiny reservoirs for medicines or even sensors that would alert a person in critical instances, such as when blood-sugar levels change.
The technology, McShane notes, affords researchers a high degree of control over what is delivered to the body, where and when it is delivered and how much of it is delivered. That degree of flexibility, he says, could make the system an extremely useful tool when it comes to targeted drug delivery.
As opposed to having patients simply swallow a pill, health care professionals have long envisioned delivering specific quantities of medicines to targeted areas of the body, thereby increasing the treatment’s effectiveness while reducing side effects. In order to achieve this, a “vehicle” of sorts is needed to safely and accurately deliver the medicine to the desired location within the body.
McShane’s team, which also includes graduate student Dustin Ritter, is building that vehicle using a modified Jell-O-like substance known as a hydrogel. A hydrogel is a polymer mesh material that is typically biocompatible, meaning it allows cells within the body to conduct normal physiological processes without triggering an immune response from the host. Because of this, hydrogels are widely used in tissue engineering research, and they can be found in a number of other applications, most commonly as the material from which contact lenses are made.
Although hydrogels aren’t new, the ones employed in McShane’s carrier system aren’t typical; they’ve been enhanced. Specifically, they are embedded with tiny capsules that are significantly smaller than the width of a human hair. Each of these microcapsules serves as a reservoir or depot for the material doctors and researchers want to deliver, such as a drug.
Measuring a few microns in diameter, these porous microparticles are made from clusters of calcium carbonate nanoparticles that have been deliberately formed around a specific material to trap it inside, McShane notes. Once the desired material is trapped within the microsphere, multiple layers of polymers are wrapped around the particles, he explains. This allows for a precise and customizable control over how the microcapsule will release its contents when it interacts with its surrounding environment, McShane explains.
The system, McShane says, is not limited to drug delivery. In fact, it has shown promising results with biosensors. In these types of applications, he explains, the microcapsules carry a payload, such as a protein, that is responsive to something in the body that doctors want to measure. This measurable material is allowed to pass into the hydrogel and into the capsules where it triggers some type of optical change, he says. For example, McShane has been able to trigger a color change in the material (observable with a reader device) when pH and oxygen levels change or when blood-sugar levels fluctuate. It’s work that could translate into safer and more effective ways for people, such as those suffering from diabetes, to monitor their conditions.
The Latest on: Targeted drug delivery
[google_news title=”” keyword=”Targeted drug delivery” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Targeted drug delivery
- Avidity Biosciences: Strong Buy With Promising RNA Therapeutics Pipelineon May 19, 2024 at 8:23 am
Avidity Biosciences, a leading biotech company, shows promising results in clinical trials for their drug candidate del-desiran.
- NurExone Welcomes Biopharma Exec Dr. Ram Petter to Drive Strategic Collaborationson May 17, 2024 at 1:28 pm
"Our ExoTherapy platform for drug delivery is ready for industry partnerships targeting clinical indications beyond acute spinal cord injury," says Dr. Lior Shaltiel, CEO of NurExone. "Ram’s extensive ...
- Plus Therapeutics Announces New Employment Inducement Grantson May 17, 2024 at 10:01 am
Combining image-guided local beta radiation and targeted drug delivery approaches, the Company is advancing a pipeline of product candidates with lead programs in recurrent glioblastoma (GBM) and ...
- Key advantages of using biodegradable microspheres as targeted drug delivery systemson May 14, 2024 at 10:21 pm
Biodegradable microspheres are new, targeted drug delivery systems that are becoming increasingly popular in the field of drug design. A key characteristic among the various advantages of ...
- Drug delivery articles from across Nature Portfolioon May 12, 2024 at 5:00 pm
and drug accumulation persist. Here the authors show a molecular library design centered on cyclic tertiary amine compounds and develop a self-enhanced brain-targeted nucleic acid delivery system ...
- Nature's Blueprint: Biodegradable Materials in Engineered Drug Delivery Systemson May 7, 2024 at 1:09 am
In the field of pharmaceutical sciences, drug is delivered either by conventional mode or controlled/ targeted mode to treat the disease. In controlled drug delivery, drug concentration is maintained ...
- Targeted Drug Delivery: Precision Medicine at the Nanoscaleon May 5, 2024 at 11:34 am
What is Targeted Drug Delivery? Targeted drug delivery is a cutting-edge approach in nanomedicine that aims to selectively transport therapeutic agents to specific tissues, cells, or even ...
- New molecular device unlocks potential for targeted drug delivery and self-healing materialson April 10, 2024 at 3:57 pm
It also holds promise for self-healing materials that can repair themselves in situ when damaged, prolonging the lifespan of these materials. For example, a scratch on a phone screen. Guillaume De ...
- Customized vectors for targeted drug deliveryon September 2, 2020 at 4:11 am
The delivery of therapeutics to target areas continues to be a challenge for drug developers. Getting drugs to their site of action is crucial to increase their efficacy and reduce toxicity.
- Precision Nanomedicines for Targeted Drug Deliveryon August 19, 2020 at 9:16 am
Kidney-Targeted Therapeutics: We are synthesizing nanoparticles that specifically target the kidneys. These will facilitate the development of new medicines to address many types of kidney diseases.
via Bing News